Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > D.C. Eyes Donald Trump Jr. Over Misspent Inaugural Funds
View:
Post by ScienceFirst on Jan 18, 2021 1:04pm

D.C. Eyes Donald Trump Jr. Over Misspent Inaugural Funds

Stevenbrainwashed will probably discredit this one ... lolll  

That's just a repeat of the misuse of funds like in the case of the Trump Foundation that was caught cheating.The Trump family is used to gimmick and once again proved that it is a crooked one, manipulating its innocent base.


D.C. Eyes Donald Trump Jr. Over Misspent Inaugural Funds (lawandcrime.com)
 

The Washington, D.C. Attorney General’s office would like a word with Donald Trump Jr. over an allegedly unlawful misuse of presidential inauguration committee funds.

According to a non-public notice to sit for a sworn deposition in an ongoing civil lawsuit, the 45th president’s eldest son has some explaining to do under oath, a spokesperson for the D.C. Attorney General’s office told Law&Crime.

Originally filed in January 2020 by D.C. Attorney General Karl Racine, that lawsuit initially alleged the inaugural committee “improperly paid more than $1 million” to the Trump Organization “for use of event space at the Trump Hotel” in Washington, D.C. during President Donald Trump‘s 2017 inauguration.

Two recent filings have added new dimensions — and an additional charge — to that lawsuit.

“This amended complaint adds an additional count against Defendants 58th Presidential inaugural Committee (PIC) and the Trump Organization for violating the District’s statutory and Common law,” a Monday filing by D.C. Assistant Attorney General Leonor Miranda says. “Discovery in this case has confirmed that the PIC improperly paid almost $50,000 for hotel rooms reserved by the Trump Organization. This new instance of improper spending of nonprofit funds is the focus of an additional count in the District’s First Amended Complaint.”

The new charge is unrelated to the use of Trump Hotel event space; rather, it concerns the Trump Organization allegedly acting on behalf of the younger Trump and one of his associates.

“In December 2016, the Trump Organization reserved a block of hotel rooms at the Madison, a Loews Hotel (Loews Madison) in Washington, D.C. during the January 2017 inauguration week,” the second filing alleges. “This reservation was arranged by the personal assistant to Donald Trump, Jr. at the Trump Organization. The contract was executed on behalf of the Trump Organization by a close friend of Donald Trump, Jr. named Gentry Beach.”

“The [Presidential inaugural Committee] was not a party to this contract,” the filing continues.

The two new documents are styled as: (1) a motion for leave to amend the original complaint; and (2) a proposed order containing the new complaint and allegation.

Notably, former Trump 2016 campaign aide and Paul Manafort‘s erstwhile protg Rick Gates also makes an appearance in the documents. From the motion for leave:

When the Trump Organization failed to pay the Loews Madison $49,358.92 for use of those hotel rooms, the unpaid invoice wound its way from a debt collection agency in Arizona to Rick Gates, a former Trump campaign and PIC official, who passed the unpaid invoice along to the PIC. Then, in July 2017, the PIC paid this debt of the Trump Organization using nonprofit funds meant to serve a public purpose. When it did so, the PIC’s nonprofit funds improperly inured to the benefit of the Trump Organization in violation of the District’s Nonproft Corporations Act and common law. The District’s request to amend its Complaint to add an additional count against the PIC and the Trump Organization to recover these additional misspent nonprofit funds is proper and should be granted.

Comment by Pandora on Jan 18, 2021 1:37pm
Hey Science how about giving us a matching dissertation on the performance of one Hunter Biden or is that against your "storied" principles? You only throw the s--t in one direction.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250